Respond to each students posts regarding the following question. Please put the names of the person to who you are responding too

profiledream86
COH315D2Respondtoeachstudentspostsminimum1paragraheachregardingthefollowingquestion.seeattachment.docx

Respond to each students posts regarding the following question. Please put the names of the person to who you are responding too.

Experimental Studies

In your post, you are to select a disease that no one else has selected. You can post early in the week to reserve your disease and then just reply to your original post when your material is done. Answer the following questions with your initial post.

1. What disease did you select?

2. Find two different incidence rates for this disease. This can be either the rates of the disease in two different countries, age groups, ethnicities, occupation, or any other classifier that might be important to your disease. Provide the two different rates here. Cite your source.

3. Select a screening test or a confirmatory test for your disease. Report on what the sensitivity and specificity percentages are and cite your source. Also, provide the cost of the test.

4. Using the method outlined in the excel document determine the PPV and NPV of using both screening tests in the two populations you selected.

5. How much did each true positive cost?

6. Does it make sense to implement mandatory screening in either population? Why or why not?

The initial response is due by 11:59 pm Thursday of Week 2.

Please respond to at least two of your fellow students by Sunday at 11:59 pm. These posts should critically engage your fellow student. Try bringing in a news article, journal article, or some other research to discuss what the limitations are that may have been missed. Consider the natural history of the disease.

3

QUESTION:

Mikayla Anoje 

RE: Influenza

COLLAPSE

Top of Form

1. What disease did you select?

a. Influenza

2. Find two different incidence rates for this disease. This can be either the rates of the disease in two different countries, age groups, ethnicities, occupation, or any other classifier that might be important to your disease. Provide the two different rates here. Cite your source.

a. The statistical estimate of influenza incidence among all ages ranged from 3.0%–11.3% among seasons

i. median values of 8.3% for all ages

ii. 9.3% for children <18 years

iii.  8.9% for adults 18–64 years (Tokars, Olson, & Reed, 2018)

1. I am somewhat surprised by these numbers because every study I have read has touched on how the elderly population is at higher risk for contracting and dying from influenza than any other population. I think this is mostly due to their diminishing immune systems and the suffering from other underlying diseases that come with old age. Children my contract the virus but it does not have a large impact on their health due to the resiliency of the younger population. I think that the numbers show that the younger population gets it more because they are more active in group settings such as daycare and school than the older patients.

 

1. Select a screening test or a confirmatory test for your disease. Report on what the sensitivity and specificity percentages are and cite your source. Also, provide the cost of the test.

a. Sensitivities of RIDTs are generally approximately 50-70%, but a range of 10-80% has been reported compared to viral culture or RT-PCR.

b. Specificities of RIDTs are approximately 90-95% (range 85-100%). Thus false negative results occur more commonly than false positive results. (Centers for Disease Control and Prevention, 2016)

c. Rapid flu test costs $5.00 to $10.00 (Zimmerman, 2018)

 

1. Using the method outlined in the excel document determine the PPV and NPV of using both screening tests in the two populations you selected.

a. Children <18 years        

i. PPV      82.16%

ii. NPV     90.47%

b. Adults 18-64 years        

i. PPV      5.66%

ii. NPV     100.00%

 

1. How much did each true positive cost?

Cost of Test

 

$10

 

 

 

Children <18 years

Cost per Positive

1000 x $10 = $ 10,000

$10,000/175 = $57 dollars per positive found

Adults 18-64 years

Cost per Positive

1000 x $10 = $ 10,000

$10,000/3 = $3,333 dollars per positive found

 

1. Does it make sense to implement mandatory screening in either population? Why or why not?

a. Although $57 is inexpensive compared to $3000, given the nature of the illness and the advances in medicine we have today, I don’t think implementing mandatory testing is appropriate. $57 could add up fast for families with multiple children and if the patient is asymptomatic the testing is not necessary.

References

Centers for Disease Control and Prevention. (2016, 10 25). Influenza (Flu). Retrieved from cdc.gov: https://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm#:~:text=Sensitivities%20of%20RIDTs%20are%20generally,commonly%20than%20false%20positive%20results.

Tokars, J. I., Olson, S. J., & Reed, C. (2018). Seasonal Incidence of Symptomatic Influenza in the United States. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66(10), 1511–1518. Retrieved from https://doi.org/10.1093/cid/cix1060

Zimmerman, B. (2018, February 8). 3 things to know about rapid flu tests. Retrieved from Beckers Clinical Leadership & Infection Control: https://www.beckershospitalreview.com/quality/3-things-to-know-about-rapid-flu-tests.html#:~:text=RIDTs%20rely%20on%20samples%20from,can%20cost%20more%20than%20%24200.

Bottom of Form

Sheri Groves Wills 

Varicella-Zoster Virus

COLLAPSE

Top of Form

What disease did you select?

Varicella-Zoster Virus

Find two different incidence rates for this disease. This can be either the rates of the disease in two different countries, age groups, ethnicities, occupation, or any other classifier that might be important to your disease. Provide the two different rates here. Cite your source.

The incidence for herpes zoster is approximately 4 cases per 1,000 U.S. population annually, age-adjusted to the 2000 U.S. population The incidence among people 60 years of age and older is about 10 cases per 1,000 U.S. population annually There are an estimated one million cases of herpes zoster in the United States annually.

Shingles | Clinical Overview - Varicella Vaccine | Herpes Zoster | CDCThis clinical overview provides information on clinical features, complications, vaccination, transmission and more of herpes zoster, or zoster or shingles.

Select a screening test or a confirmatory test for your disease. Report on what the sensitivity and specificity percentages are and cite your source. Also, provide the cost of the test.

Test ID: VZGM

Varicella-Zoster Antibody, IgM and IgG (Separate Determinations), Serum

In this study the sensitivity was 92.2% from specimens with 10-14 days of appearance of virus. Confidence Interval (95% CI): 89.4%-94.3%

Specificity: 100.0 (22/22); 95% CI: 82.5%-100.0%

VZGM - Clinical: Varicella-Zoster Antibody, IgM and IgG, SerumVZGM : Varicella-zoster virus (VZV), a herpesvirus, causes 2 distinct exanthematous (rash-associated) diseases: chickenpox (varicella) and shingles (herpes zoster). Chickenpox is a highly contagious, though typically benign disease, usually contracted during childhood. Chickenpox is characterized by a dermal vesiculopustular rash that develops in successive crops approximately 10 to 21 days following exposure.(1) Although primary infection with VZV results in immunity and protection from subsequent infection, VZV remains latent within sensory dorsal root ganglia and upon reactivation, manifests as herpes zoster or shingles. During reactivation, the virus migrates along neural pathways to the skin, producing a unilateral rash, usually limited to a single dermatome. Shingles is an extremely painful condition typically occurring in older nonimmune adults or those with waning immunity to VZV and in patients with impaired cellular immunity.(2)   Individuals at risk for severe complications following primary VZV infection include pregnant women, in whom the virus may spread through the placenta to the fetus causing congenital disease in the infant. Additionally, immunosuppressed patients are at risk for developing severe VZV-related complications, which include cutaneous disseminated disease and visceral organ involvement.(2,3)   Serologic screening for IgG-class antibodies to VZV will aid in identifying nonimmune individuals. The presence of IgM-class antibodies to VZV is suggestive of acute or recent infection however results should be correlated with clinical presentation.

Another study I found was in the National Institute of Health and they just reassure the positive duration of the varicella zoster virus IgM test in herpes zoster because if this test is done in larger periods of time 2 days- 40 weeks the sensitivity result drops to 23%.

The positive duration of varicella zoster immunoglobulin M antibody test in herpes zosterLaboratory tests for herpes zoster (HZ) are required to confirm varicella zoster virus (VZV) infection, especially when a skin lesion is not typical or apparent. The serological test for VZV IgM antibody is simple and cost-effective; however, the change ...PubMed Central (PMC)

Using the method outlined in the excel document determines the PPV and NPV of using both screening tests in the two populations you selected.

 

How much did each true positive cost? The approximate cost for this screen test is $45.

Order Routine Blood Tests Online Without Insurance | Walk-In LabGet direct access lab testing from Walk-In Lab. Cheap, convenient, and confidential blood tests for allergies, cancer, STDs and much more. Order online today!Walk-In Lab

Does it make sense to implement mandatory screening in either population? Why or why not? 

The cost is $45 but this is a fairly known virus and doctors are familiar with the symptoms and appearance of the virus. It does make sense to have this test done just to verify within the 2-3 weeks because after that according to another study specified above it would be negative.

Bottom of Form

Bottom of Form